Group One Trading’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Group One Trading's DNA Position: Q3 2026 in Review
Group One Trading increased its Ginkgo Bioworks (DNA) stake by 9% in Q3 2026, buying an estimated $24.1K and bringing the position to 35,868 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #3472.
Group One Trading first reported a position in DNA in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.07M in Q1 2024. 151 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Group One Trading held 35,868 shares of Ginkgo Bioworks worth $460K as of Q3 2026.
- Group One Trading bought 2,958 Ginkgo Bioworks shares in Q3 2026, an estimated $24.1K.
- Ginkgo Bioworks made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #3472 holding.
- Group One Trading first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 15 quarters since.
- Group One Trading's Ginkgo Bioworks position peaked at $1.07M in Q1 2024.
- 151 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.